Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022		29,718,000
Beginning balance at Dec. 31, 2022	$ 249,398	$ 3	$ 599,234	$ (348,715)	$ (1,124)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock option exercises (in shares)		4,000
Stock option exercises	23		23
Stock-based compensation expense	3,882		3,882
Issue common stock, net of issuance costs (in shares)		950,000
Issue common stock, net of issuance costs	14,848		14,848
Issuance of common stock due to the vesting of restricted stock units, net of shares withheld to cover taxes (in shares)		7,000
Net loss	(37,124)			(37,124)
Other comprehensive income (loss)	459				459
Ending balance (in shares) at Mar. 31, 2023		30,679,000
Ending balance at Mar. 31, 2023	$ 231,486	$ 3	617,987	(385,839)	(665)
Beginning balance (in shares) at Dec. 31, 2023	45,752,000	45,752,000
Beginning balance at Dec. 31, 2023	$ 96,157	$ 5	677,337	(581,208)	23
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock option exercises (in shares)	0
Stock-based compensation expense	$ 3,015		3,015
Issue common stock, net of issuance costs (in shares)		11,787,000
Issue common stock, net of issuance costs	15,060	$ 1	15,059
Net loss	(31,422)			(31,422)
Other comprehensive income (loss)	$ (39)				(39)
Ending balance (in shares) at Mar. 31, 2024	57,539,000	57,539,000
Ending balance at Mar. 31, 2024	$ 82,771	$ 6	$ 695,411	$ (612,630)	$ (16)